Cytokines in the pathogenesis of systemic lupus erythematosus

Seminars in Nephrology

Volumn 19, Issue 1, 1999, Pages 57-66

  Kelley, Vicki Rubin ^a,c   Wüthrich, Rudolf P ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CELL ADHESION; CYTOKINES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; SENSITIVITY AND SPECIFICITY;

EID: 0032936962     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Floege J, Rees A: Growth factors and cytokines, in Neilson EG, Couser WO (eds): Immunologie Renal Diseases. Philadelphia, PA, Lippincott-Raven, 1997, pp 417-454
2. Wang JM, Griffin JD, Rambaldi A, et al: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 141:575-579, 1988
3. Nicola NA, Metcalf D: Specificity of action of colonystimulating factors in the differentiation of granulocytes and macrophages. Ciba Found Symp 118:7-28, 1986
4. Yui MA, Brissette WH, Brennan DC, et al: Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-Ipr mice. Am J Pathol 139:255-261, 1991
5. Bloom RD, Florquin S, Singer GG, et al: Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int 43:1000-1009, 1993
6. Naito T, Griffiths RC, Coffman TM, et al: Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice. Kidney Int 49:67-74, 1996
7. Brennan DC, Jevnikar AM, Bloom RD, et al: Cultured mesangial cells from autoimmune MRL-lpr mice have decreased secreted and surface M-CSF. Kidney Int 42:279-284, 1992
8. Wada T, Naito T, Griffiths RC, et al: Systemic autoimmune nephritogenic components induce CSF-1 and TNF-α in MRL kidneys. Kidney Int 52:934-941, 1997
9. Naito T, Yokoyama H, Moore KJ, et al: Macrophage growth factors introduced into the kidney initiate renal injury. Mol Med 2:297-312, 1996
10. Moore KJ, Naito T, Martin C, et al: Enhanced response of macrophages to CSF-1 in autoimmune mice: A gene transfer strategy. J Immunol 157:433-440, 1996
11. Yokoyama H, Kreft B, Kelley VR: Biphasic increase in circulating and renal TNF-a in MRL-lpr mice with differing regulatory mechanisms. Kidney Int 47:122-130, 1995
12. Moore KJ, Yeh K, Naito T, et al: TNF-α enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease. J Immunol 157:427-432, 1996
13. Frank J, Engler-Blum G, Rodemann HP, et al: Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1:26-35, 1993
14. Naito T, Yokoyama H, Moore KJ, et al: A gene transfer system establishes interleukin-6 neither promotes nor suppresses renal injury. Am J Physiol 271:F603-F609, 1996
15. Rovin BH, Phan LT: Chemotactic factors and renal inflammation. Am J Kidney Dis 31:1065-1084, 1998
16. Rollins BJ: Chemokines. Blood 90:909-928, 1997
17. Cook DN, Beck MA, Coffman TM, et al: Requirement of MIP-1-α for an inflammatory response to viral infection. Science 269:1583-1585, 1995
18. Lu B, Rutledge BJ, Gu L, et al: Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-608,1998
19. Zachariae CO, Anderson AO, Thompson HL, et al: Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 171:2177-2182, 1990
20. Carr MW, Roth SJ, Luther E, et al: Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci (USA) 91:3652-3656, 1994
21. Rovin BH, Rumancik M, Tan L, et al: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71:536-542, 1994
22. Stahl RA, Thaiss F, Disser M, et al: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 44:1036-1047, 1993
23. Tang WW, Qi M, Warren JS, et al: Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 159: 870-876, 1997
24. Hora K, Satriano JA, Santiago A, et al: Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc Natl Acad Sci USA 89:1745-1749, 1992
25. Rovin BH, Yoshiumura T, Tan L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153, 1992
26. Rovin BH, Doe N, Tan LC: Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27:640-646, 1996
27. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
28. Boring L, Gosling J, Chensue SW, et al: Impaired monocyte migration and reduced type 1 (Thl) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561, 1997
29. Kurihara T, Warr G, Loy J, et al: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757-1762, 1997
30. Kuziel WA, Morgan SJ, Dawson TC, et al: Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94:12053-12058, 1997
31. Lloyd CM, Dorf ME, Proudfoot A, et al: Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol 62:676-680, 1997
32. Heeger P, Wolf G, Meyers C, et al: Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int 41:220-225, 1992
33. Schall TJ, Bacon K, Toy KJ, et al: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671, 1990
34. Gilat D, Hershkoviz R, Mekori YA, et al: Regulation of adhesion of CD4+ T lymphocytes to intact or heparinasetreated subendothelial extracellular matrix by diffusible or anchored rantes and M1P-1β. J Immunol 153:4899-4906, 1994
35. 1pr mice. Kidney Int 53:1631-1641, 1998
36. Wuthrich RP: The complex role of osteopontin in renal disease. Nephrol Dial Transplant 1998 13:2448-2450
37. Pichler R, Giachelli CM, Lombardi D, et al: Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
38. Lan HY, Yu XQ, Yang N, et al: De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 53:136-145, 1998
39. 1pr mice with lupus nephritis. Autoimmunity 1998 (in press)
40. Patarca R, Wei FY, Singh P, et al: Dysregulated expression of the T cell cytokine Eta-1 in CD4-8-lymphocytes during the development of murine autoimmune disease. J Exp Med 172:1177-1183, 1990
41. Lampe MA, Patarca R, Iregui MV, et al: Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 147:2902-2906, 1991
42. Liaw L, Birk DE, Bailas GB, et al: Altered wound healing in mice lacking a functional osteopontin gene (spp 1). J Clin Invest 101:1468-1478, 1998
43. Rittling SR, Matsumoto HN, McKee MD, et al: Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101-1111, 1998
44. Wüthrich RP, Glimcher LH, Yui MA, et al: MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37:783-792, 1990
45. Jevnikar AM, Brennan DC, Singer GG, et al: Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF-a. Kidney Int 40:203-211, 1991
46. Black RA, Rauch CT, Kozlosky CJ, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-a from cells. Nature 385:729-733, 1997
47. Moss ML, Jin SL, Milla ME, et al: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733-736, 1997
48. Boswell JM, Yui MA, Burt DW, et al: Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J Immunol 141:3050-3054, 1988
49. Brennan DC, Yui MA, Wüthrich RP, et al: Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol 143:3470-3475, 1989
50. Lemay S, Mao C, Singh AK: Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney Int 50:85-93, 1996
51. Murray LJ, Lee R, Martens C: In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur J Immunol 20:163-170, 1990
52. Murray L, Martens C: Abnormal T cells from lpr mice down-regulate transcription of interferon-γ and tumor necrosis factor-α in vitro. Cell Immunol 126:367-376, 1990
53. Jacob CO, McDevitt HO: Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature 331:356-358, 1988
54. Jacob CO, Lee SK, Strassmann G: Mutational analysis of TNF-α gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol 156:3043-3050, 1996
55. D'Alfonso S, Colombo G, Delia Bella S, et al: Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47:551-555, 1996
56. Danis VA, Millington M, Hyland V, et al: Increased frequency of the uncommon allele of a tumour necrosis factor a gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 12:127-133, 1995
57. Gordon C, Ranges GE, Greenspan JS, et al: Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW Fl mice. Clin Immunol Immunopathol 52: 421-434, 1989
58. Jacob CO, Hwang F, Lewis GD, et al: Tumor necrosis factor a in murine systemic lupus erythematosus disease models: Implications for genetic predisposition and immune regulation. Cytokine 3:551-561, 1991
59. Zhou T, Edwards CK3, Yang P, et al: Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J Immunol 156:26612665, 1996
60. Wiithrich RP: Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 42:903-914, 1992
61. Wiithrich RP, Jevnikar AM, Takei F, et al: Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol 136:441-450, 1990
62. Wiithrich RP: Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol 3:1201-1211, 1992
63. Sedor JR: Interleukin-1: A master cytokine in the renal response to injury, in Schlondorff D, Bonventre JV (eds): Molecular Nephrology. New York, NY, Marcel Dekker, Inc, 1995, pp 631-652
64. Boswell JM, Yui MA, Endres S, et al: Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol 141:118-124, 1988
65. Prud'homme GJ, Kono DH, Theofilopoulos AN: Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-lj3, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol Immunol 32:495-503, 1995
66. Mao C, Singh AK: IL-1β gene expression in B cells derived from the murine MRL/lpr model of lupus. Autoimmunity 24:71-79, 1996
67. Billiau A: Interferon-y in autoimmunity. Cytokine Growth Factor Rev 7:25-34, 1996
68. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787-793, 1996
69. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
70. Erbe DV, Collins JE, Shen L, et al: The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol Immunol 27:57-67, 1990
71. Heagy W, Kelley VE, Strom TB, et al: Decreased expression of human class II antigens on monocy tes from patients with acquired immune deficiency syndrome. Increased expression with interferon-y. J Clin Invest 74:2089-2096, 1984
72. Haas C, Ryffel B, Le Hir M: IFN-y is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 158:5484-5491, 1997
73. lpr mice. J Immunol 161:494-503, 1998
74. Balomenos D, Rumold R, Theofilopoulos AN: Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 101:364-371, 1998
75. Haas C, Ryffel B, Le Hir M: IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZBxNZW)Fl mice. J Immunol 160:3713-3718, 1998
76. lpr autoimmune interstitial nephritis: a negative regulatory pathway. J Immunol 160:4074-4081, 1998
77. Diaz Gallo C, Kelley VR: Self-regulation of autoreactive kidney-infiltrating T cells in MRL-lpr nephritis. Kidney Int 44:692-699, 1993
78. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
79. Kitamura M, Sütö TS: TGF-β and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669-679, 1997
80. Munger JS, Harpel JG, Gleizes PE, et al: Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
81. Yamamoto T, Noble NA, Cohen AH, et al: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
82. Okuda S, Languino LR, Ruoslahti E, et al: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
83. Yamamoto T, Noble NA, Miller DE, et al: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
84. Ketteier M, Noble NA, Border WA: Transforming growth factor-β and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 57:279-295, 1995
85. Isaka Y, Fujiwara Y, Ueda N, et al: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
86. Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
87. Kulkarni AB, Huh CG, Becker D, et al: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774, 1993
88. Kulkarni AB, Ward JM, Yaswen L, et al: Transforming growth factor-β1 null mice. An animal model for inflammatory disorders. Am J Pathol 146:264-275, 1995
89. Dang H, Geiser AG, Letterio JJ, et al: SLE-Iike autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-β knockout mice. J Immunol 155:3205-3212, 1995
90. Kreft B, Yokoyama H, Naito T, et al: Dysregulated transforming growth factor-β in neonatal and adult autoimmune MRL-lpr mice. J Autoimmun 9:463-472, 1996
91. Raz E, Dudler J, Lotz M, et al: Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4:286-292, 1995